<!DOCTYPE html>
<html>
    <head>
        <title>28</title>

    </head>
    <body>
        <div data-role="page" id="c28-t" data-theme="a">
            <div data-id="quickpick-header" data-role="header" data-theme="b" data-position="fixed"><a href="c25-clv.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h1>Condition Quick Pick</h1>
        <a href="#nav-panel" class="ui-btn ui-icon-bars ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>    </div>
            <div data-role="content" data-theme="a" >
                <div id=quickpick_breadcrumbs>
                
                        <a href="c0-clv.html" >Condition Quick Pick</a><span class="carrot"> > </span>
                        <a href="c25-clv.html" >Hepatitis</a><span class="carrot"> > </span>Hepatitis C
                </div>   <!-- end of quick pick breadcrumbs -->
                </br><h2 class="sgc-1" id="sigil_toc_id_366">
 Diagnosis and Treatment
</h2>
<p>
 Anti-HCV testing is recommended for routine screening of asymptomatic persons based on their risk for infection or based on a recognized exposure (see Hepatitis C, Prevention). For such persons, testing for HCV infection should include the use of an FDA-cleared test for antibody to HCV (i.e., immunoassay,&nbsp;EIA, or enhanced chemiluminescence imunoassay and, if recommended, a supplemental antibody test) (468).
</p>
<p>
 Persons counseled and tested for HCV infection and determined to be anti-HCV positive should be evaluated (by referral or consultation, if appropriate) for the presence of active infection, presence or development of CLD, and possible treatment. Nucleic acid testing, including reverse transcriptase polymerase chain reaction (RT-PCR) to detect HCV RNA, is necessary to confirm the diagnosis of current HCV infection, and an elevated ALT level is biochemical evidence of CLD. Combination therapy with pegylated interferon and ribavirin is the treatment of choice for patients with chronic hepatitis C. Providers should consult with specialists knowledgeable about management of hepatitis C infection because these experts remain cognizant of the latest advances in the field of antiviral therapy for acute and chronic hepatitis C.
</p>

            <div data-role="footer" data-id="regimens-footer" data-position="fixed" class="tab_treatment">
                <div data-role="navbar" class="tab_icons" data-iconpos="left">
                    <ul>
                        <li><a href="#" class="ui-disabled" id="treat_inactive" data-theme="a" data-icon="custom">Treatments</a></li>
                        <li><a href="#" id="info_active" data-theme="b" class="ui-btn-active ui-state-persist" data-icon="custom">More Info</a></li>
                    </ul>
                </div>
            </div>

        </div>
        
        <div data-role="panel" data-display="push" data-theme="b" id="nav-panel">
            <ul data-role="listview">
                <li data-icon="delete"><a href="#" data-rel="close">Close menu</a></li>
                <li><a href="../conditions/c0-clv.html">Condition Quick Pick</a></li>
                <li><a href="../guidelines/lv-0.html">Full STD Tx Guidelines</a></li>
                <li><a href="../page/hx-pdf.html">Taking a Sexual Hx PDF</a></li>
                <li><a href="../terms/1.html">Terms and Abbreviations</a></li>
                <li><a href="../refs/lv-0.html">References</a></li>
                <li><a href="../page/about_us.html">About Us</a></li>
            </ul>
        </div><!-- /panel -->
    
        </div>
    </body>
</html>
        